Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

At Home Molecular Testing Market

ID: MRFR/HC/35120-HCR
100 Pages
Satyendra Maurya
Last Updated: April 24, 2026

At-Home Molecular Testing Market Research Report By Test Type (Genetic Testing, Infectious Disease Testing, Cancer Testing, Hormonal Testing), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Microarray, CRISPR), By Sample Type (Saliva, Blood, Urine, Tissue), By End Use (Home Users, Healthcare Professionals, Research Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

At Home Molecular Testing Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Test Type (USD Billion) | |
      1. 4.1.1 Genetic Testing | |
      2. 4.1.2 Infectious Disease Testing | |
      3. 4.1.3 Cancer Testing | |
      4. 4.1.4 Hormonal Testing |
    2. 4.2 Healthcare, BY Technology (USD Billion) | |
      1. 4.2.1 Polymerase Chain Reaction | |
      2. 4.2.2 Next-Generation Sequencing | |
      3. 4.2.3 Microarray | |
      4. 4.2.4 CRISPR |
    3. 4.3 Healthcare, BY Sample Type (USD Billion) | |
      1. 4.3.1 Saliva | |
      2. 4.3.2 Blood | |
      3. 4.3.3 Urine | |
      4. 4.3.4 Tissue |
    4. 4.4 Healthcare, BY End Use (USD Billion) | |
      1. 4.4.1 Home Users | |
      2. 4.4.2 Healthcare Professionals | |
      3. 4.4.3 Research Institutions |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Abbott Laboratories (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Thermo Fisher Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Roche Diagnostics (CH) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Siemens Healthineers (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Cepheid (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Hologic (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Bio-Rad Laboratories (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 QuidelOrtho Corporation (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TEST TYPE |
    7. 6.4 US MARKET ANALYSIS BY TECHNOLOGY |
    8. 6.5 US MARKET ANALYSIS BY SAMPLE TYPE |
    9. 6.6 US MARKET ANALYSIS BY END USE |
    10. 6.7 CANADA MARKET ANALYSIS BY TEST TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY TECHNOLOGY |
    12. 6.9 CANADA MARKET ANALYSIS BY SAMPLE TYPE |
    13. 6.10 CANADA MARKET ANALYSIS BY END USE |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY TEST TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
    17. 6.14 GERMANY MARKET ANALYSIS BY SAMPLE TYPE |
    18. 6.15 GERMANY MARKET ANALYSIS BY END USE |
    19. 6.16 UK MARKET ANALYSIS BY TEST TYPE |
    20. 6.17 UK MARKET ANALYSIS BY TECHNOLOGY |
    21. 6.18 UK MARKET ANALYSIS BY SAMPLE TYPE |
    22. 6.19 UK MARKET ANALYSIS BY END USE |
    23. 6.20 FRANCE MARKET ANALYSIS BY TEST TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
    25. 6.22 FRANCE MARKET ANALYSIS BY SAMPLE TYPE |
    26. 6.23 FRANCE MARKET ANALYSIS BY END USE |
    27. 6.24 RUSSIA MARKET ANALYSIS BY TEST TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
    29. 6.26 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END USE |
    31. 6.28 ITALY MARKET ANALYSIS BY TEST TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY TECHNOLOGY |
    33. 6.30 ITALY MARKET ANALYSIS BY SAMPLE TYPE |
    34. 6.31 ITALY MARKET ANALYSIS BY END USE |
    35. 6.32 SPAIN MARKET ANALYSIS BY TEST TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
    37. 6.34 SPAIN MARKET ANALYSIS BY SAMPLE TYPE |
    38. 6.35 SPAIN MARKET ANALYSIS BY END USE |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USE |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY TEST TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY TECHNOLOGY |
    46. 6.43 CHINA MARKET ANALYSIS BY SAMPLE TYPE |
    47. 6.44 CHINA MARKET ANALYSIS BY END USE |
    48. 6.45 INDIA MARKET ANALYSIS BY TEST TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY TECHNOLOGY |
    50. 6.47 INDIA MARKET ANALYSIS BY SAMPLE TYPE |
    51. 6.48 INDIA MARKET ANALYSIS BY END USE |
    52. 6.49 JAPAN MARKET ANALYSIS BY TEST TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
    54. 6.51 JAPAN MARKET ANALYSIS BY SAMPLE TYPE |
    55. 6.52 JAPAN MARKET ANALYSIS BY END USE |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USE |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY TEST TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END USE |
    64. 6.61 THAILAND MARKET ANALYSIS BY TEST TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
    66. 6.63 THAILAND MARKET ANALYSIS BY SAMPLE TYPE |
    67. 6.64 THAILAND MARKET ANALYSIS BY END USE |
    68. 6.65 INDONESIA MARKET ANALYSIS BY TEST TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
    70. 6.67 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END USE |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY TEST TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END USE |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY TEST TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
    79. 6.76 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END USE |
    81. 6.78 MEXICO MARKET ANALYSIS BY TEST TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
    83. 6.80 MEXICO MARKET ANALYSIS BY SAMPLE TYPE |
    84. 6.81 MEXICO MARKET ANALYSIS BY END USE |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY TEST TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END USE |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USE |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USE |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY TEST TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END USE |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY END USE, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END USE, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END USE, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END USE, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END USE, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END USE, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END USE, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END USE, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END USE, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END USE, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END USE, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END USE, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END USE, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END USE, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END USE, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END USE, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END USE, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END USE, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END USE, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END USE, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END USE, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END USE, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END USE, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END USE, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END USE, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END USE, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END USE, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END USE, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END USE, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END USE, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Test Type (USD Billion, 2025-2035)

  • Genetic Testing
  • Infectious Disease Testing
  • Cancer Testing
  • Hormonal Testing

Healthcare By Technology (USD Billion, 2025-2035)

  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Microarray
  • CRISPR

Healthcare By Sample Type (USD Billion, 2025-2035)

  • Saliva
  • Blood
  • Urine
  • Tissue

Healthcare By End Use (USD Billion, 2025-2035)

  • Home Users
  • Healthcare Professionals
  • Research Institutions

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions